USF Researcher Develops Therapeutic Vaccine to Combat Alzheimer’s Disease and Neurodegenerative Disorders
30 janv. 2017 06h00 HE
|
Alzamend Neuro, Inc.
SALT LAKE CITY, Jan. 30, 2017 (GLOBE NEWSWIRE) -- Alzamend Neuro™, Inc. (Alzamend™ or the “Company”) reprints by permission of the University of South Florida (USF) Technology Transfer Office this...
Alzamend Neuro Launches Regulation A+ Tier II SEC Qualified Offering
03 janv. 2017 14h05 HE
|
Alzamend Neuro, Inc.
SALT LAKE CITY, Jan. 03, 2017 (GLOBE NEWSWIRE) -- Alzamend Neuro, Inc. (Alzamend) announced today it has launched its Regulation A+ Tier II Offering online at www.AlzamendRegA.com. The Company’s...